+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mitsubishi Tanabe Pharma Corporation - logo

Mitsubishi Tanabe Pharma manufactures pharmaceuticals, primarily ethical drugs in Japan. It focuses on the fields of circulatory system and metabolism, neuropsychiatry, the respiratory system and immunology, and oncology and hepatology. It sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. The company was founded in 1901 and is headquartered in Osaka, Japan.

From
From
Generic Musculoskeletal Disorders Drugs Market Report 2025 - Product Thumbnail Image

Generic Musculoskeletal Disorders Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Kidney Disease Market Report 2025 - Product Thumbnail Image

Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Kidney Disease Market Report 2025 - Product Thumbnail Image

Diabetic Kidney Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Thyroid Cancer Drugs Market Report 2025 - Product Thumbnail Image

Thyroid Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Pediatric Vaccine Market Report 2025 - Product Thumbnail Image

Pediatric Vaccine Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 182 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 376 Pages
  • Global
From
From
From
Ocular Hypertension Treatment Market Report 2025 - Product Thumbnail Image

Ocular Hypertension Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Spinal Cord Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator